MedTrace Logo

Myo vs. Myofascial Injection for Myofascial Trigger Points

NCT06029413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2024-08-28

No results posted yet for this study

Summary

In this study, the effectiveness of two different application methods that can be used in myofascial trigger point injection treatment will be compared.

Conditions

  • Myofascial Pain
  • Myofascial Trigger Point Pain
  • Trigger Point Pain, Myofascial

Interventions

PROCEDURE

myo + fascial injection

10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as well as for fascial layers as described.

PROCEDURE

traditional trigger point injection

10 cc 0.5 % lidocain solution injection for intermuscular hypersensitive nodule as described.

Sponsors & Collaborators

  • Bozyaka Training and Research Hospital

    lead OTHER

Principal Investigators

  • Buğra İnce · Izmir Bozyaka Education and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-26
Primary Completion
2024-07-25
Completion
2024-07-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06029413 on ClinicalTrials.gov